Thomas Haughey insider trades
Open-market stock purchases and sales by Thomas Haughey, Director at ANI Pharmaceuticals Inc, from SEC Form 4 filings since Jan 4, 2010.
Track record: 100% of 4 scored buys are up 5% or more since purchase, averaging +55%.